Novo Nordisk creates new RNA and gene therapy unit

Novo Nordisk is establishing a new technology area for RNA and gene therapy with the aim of investigating new treatments across the company's platform.

Photo: PR/Novo Nordisk

Novo Nordisk is now seriously beginning to dedicate time and resources to finding new treatment options within RNA and gene therapies, informs Senior Vice President of Global Research Technologies at Novo Nordisk Lars Fogh Iversen in a statement on Linkedin.

The company has decided to create a new technology area to focus on RNA and gene therapy, which will be anchored in the Global Research Technologies division.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs